Edition:
India

Profile: GlaxoSmithKline Pharmaceuticals Ltd (GLAX.BO)

GLAX.BO on Bombay Stock Exchange

1,485.05INR
7 Aug 2020
Change (% chg)

Rs6.05 (+0.41%)
Prev Close
Rs1,479.00
Open
Rs1,490.20
Day's High
Rs1,500.00
Day's Low
Rs1,482.25
Volume
2,450
Avg. Vol
3,944
52-wk High
Rs1,745.00
52-wk Low
Rs1,046.40

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company and its subsidiary are engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in approximately three areas, including pharmaceuticals, vaccines and consumer healthcare. The Company's product portfolio includes prescription medicines and vaccines. The Company's prescription medicines range across therapeutic areas, and it also offers a range of vaccines for prevention of life-threatening diseases, such as pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough, small pox and influenza. It provides healthcare solutions to patients, with a range of prescription medicines across areas covering anti-infectives, dermatology, gynecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The Company's manufacturing unit is located at Nashik, and its clinical development center is located in Bangalore.

Company Address

GlaxoSmithKline Pharmaceuticals Ltd

Dr Annie Besant Road, Worli
MUMBAI     400030
P: +9122.24959595
F: +9122.24981526

Company Web Links